81 – 90 of 172
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Irreversible pan-ERBB inhibitor canertinib elicits anti-leukaemic effects and induces the regression of FLT3-ITD transformed cells in mice.
Nordigården, Amanda ; Zetterblad, Jenny ; Trinks, Cecilia ; Green, Henrik ; Eliasson, Pernilla ; Druid, Pia ; Lotfi, Kourosh ; Rönnstrand, Lars LU
; Walz, Thomas M
and Jönsson, Jan-Ingvar
(2011)
In British Journal of Haematology
155.
p.198-208
- Contribution to journal › Article
-
Mark
Cytogenetic and molecular genetic characterization of the 'high hyperdiploid' B-cell precursor acute lymphoblastic leukaemia cell line MHH-CALL-2 reveals a near-haploid origin.
- Contribution to journal › Letter
-
Mark
Individualized toxicity-titrated 6-mercaptopurine increments during high-dose methotrexate consolidation treatment of lower risk childhood acute lymphoblastic leukaemia. A Nordic Society of Paediatric Haematology and Oncology (NOPHO) pilot study.
Frandsen, Thomas L ; Abrahamsson, Jonas ; Lausen, Birgitte ; Vettenranta, Kim ; Heyman, Mats ; Behrentz, Michael ; Castor, Anders LU
; Wehner, Peder S
; Frost, Britt-Marie
and Andersen, Elisabeth W
, et al.
(2011)
In British Journal of Haematology
155.
p.244-247
- Contribution to journal › Article
-
Mark
Paediatric B-cell precursor acute lymphoblastic leukaemia with t(1;19)(q23;p13): clinical and cytogenetic characteristics of 47 cases from the Nordic countries treated according to NOPHO protocols.
- Contribution to journal › Article
-
Mark
Higher risk of primary cancers after polycythaemia vera and vice versa.
Fallah, Mahdi LU
; Kharazmi, Elham
LU
; Sundquist, Jan
LU
and Hemminki, Kari
LU
(2011)
In British Journal of Haematology
153.
p.283-285
- Contribution to journal › Article
- 2010
-
Mark
Molecular characterisation of a recurrent, semi-cryptic RUNX1 translocation t(7;21) in myelodysplastic syndrome and acute myeloid leukaemia
- Contribution to journal › Article
-
Mark
Verification that common variation at 2q37.1, 6p25.3, 11q24.1, 15q23, and 19q13.32 influences chronic lymphocytic leukaemia risk
- Contribution to journal › Article
-
Mark
Should irradiated blood products be given routinely to all patients with aplastic anaemia undergoing immunosuppressive therapy with antithymocyte globulin (ATG)? A survey from the European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party
- Contribution to journal › Letter
-
Mark
The impact of bleeding history, von Willebrand factor and PFA-100 (R) on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM-1VWD
- Contribution to journal › Article
-
Mark
Maintenance treatment with azacytidine for patients with high-risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy
- Contribution to journal › Article